Impact of pre-chemotherapy locomotive syndrome status on short-term adverse outcome events in elderly lung cancer patients: A longitudinal study

doi:10.5312/wjo.v17.i3.115155

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 3

This Article

(38)

(49)

(0)

(488)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Orthopedics

ISSN

2218-5836

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Orthop. Mar 18, 2026; 17(3): 115155
Published online Mar 18, 2026. doi: 10.5312/wjo.v17.i3.115155

Table 1 Comparison of general information between the locomotive syndrome group and the non-locomotive syndrome group, n (%)

Item	LS group (n = 161)	Non-LS group (n = 225)	χ²/t/Z	P value
Gender (M/F)	57/104	110/115	4.783	0.058
Age (mean ± SD), years	69.2 ± 7.2	70.1 ± 6.9	-0.894	0.423
Educational level			1.982	0.221
Junior high school and below	79 (48.9)	89 (39.6)
High school and above	82 (51.1)	136 (60.4)
Living status			4.894	0.094
With cohabitants	98 (60.9)	157 (69.8)
Live alone	63 (39.1)	68 (30.2)
Residency			2.567	0.223
Rural	53 (32.9)	92 (40.9)
Towns	108 (67.1)	133 (59.1)
Pathological type			1.434	0.323
Adenocarcinoma	122 (75.8)	152 (67.6)
Squamous carcinoma	39 (24.2)	73 (32.4)
Staging of the tumor			0.468	0.398
Stage II	73 (45.3)	111 (49.3)
Stage III	88 (54.7)	114 (50.7)
LS after chemotherapy			78.066	< 0.001
Yes	161 (100)	87 (38.7)
No	0 (0)	138 (61.3)

M: Male; F: Female; LS: Locomotive syndrome.

Full Size Table

Citation: Liang DH, Feng XR, Li L, Chen Y, Yang YL. Impact of pre-chemotherapy locomotive syndrome status on short-term adverse outcome events in elderly lung cancer patients: A longitudinal study. World J Orthop 2026; 17(3): 115155
URL: https://www.wjgnet.com/2218-5836/full/v17/i3/115155.htm
DOI: https://dx.doi.org/10.5312/wjo.v17.i3.115155

Liang DH, Feng XR, Li L, Chen Y, Yang YL. Impact of pre-chemotherapy locomotive syndrome status on short-term adverse outcome events in elderly lung cancer patients: A longitudinal study. World J Orthop 2026; 17(3): 115155 [DOI: 10.5312/wjo.v17.i3.115155]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.